Literature DB >> 21956412

Morphological mosaicism of the pancreatic islets: a novel anatomopathological form of persistent hyperinsulinemic hypoglycemia of infancy.

C Sempoux1, C Capito, C Bellanné-Chantelot, V Verkarre, P de Lonlay, Y Aigrain, C Fekete, Y Guiot, J Rahier.   

Abstract

BACKGROUND: Morphological studies of the pancreas in persistent hyperinsulinemic hypoglycemia of infancy (PHHI) have focused on the diagnosis of focal vs. diffuse forms, a distinction that determines the optimal surgical management. ABCC8 or KCNJ11 genomic mutations are present in most of them. AIM: Our aim was to report a new form of PHHI with peculiar morphological and clinical characteristics. RESEARCH DESIGN AND METHODS: Histopathological review of 217 pancreatic PHHI specimens revealed 16 cases morphologically different from diffuse and focal forms. They were analyzed by conventional microscopy, quantitative morphometry, immunohistochemistry, and in situ hybridization.
RESULTS: Their morphological peculiarity was the coexistence of two types of islet: large islets with cytoplasm-rich β-cells and occasional enlarged nuclei and shrunken islets with β-cells exhibiting little cytoplasm and small nuclei. In small islets, β-cells had abundant insulin content but limited amount of Golgi proinsulin. Large islets had low insulin storage and high proinsulin production and were mostly confined to a few lobules. No evidence for K(ATP) channels involvement or 11p15 deletion was found. Genomic mutations for ABCC8, KCNJ11, and GCK were absent. Patients had normal birth weight and late hypoglycemia onset and improved with diazoxide. Ten were cured by limited pancreatectomy. Six recurred after surgery and were medically controlled.
CONCLUSION: This new form of PHHI is characterized by a morphological mosaicism. Pathologists should recognize this mosaicism on intraoperative frozen sections because it is often curable by partial pancreatectomy. The currently unknown genetic background does not involve the classical genomic mutations responsible for diffuse and focal PHHI.

Entities:  

Mesh:

Year:  2011        PMID: 21956412     DOI: 10.1210/jc.2010-3032

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  35 in total

1.  Clinical presentation and management of children with diffuse and focal hyperinsulinism: a review of 223 cases.

Authors:  Katherine Lord; Enyo Dzata; Kara E Snider; Paul R Gallagher; Diva D De León
Journal:  J Clin Endocrinol Metab       Date:  2013-09-20       Impact factor: 5.958

Review 2.  Hyperinsulinemic hypoglycemia: clinical, molecular and therapeutical novelties.

Authors:  Arianna Maiorana; Carlo Dionisi-Vici
Journal:  J Inherit Metab Dis       Date:  2017-06-27       Impact factor: 4.982

3.  High Risk of Diabetes and Neurobehavioral Deficits in Individuals With Surgically Treated Hyperinsulinism.

Authors:  Katherine Lord; Jerilynn Radcliffe; Paul R Gallagher; N Scott Adzick; Charles A Stanley; Diva D De León
Journal:  J Clin Endocrinol Metab       Date:  2015-09-01       Impact factor: 5.958

Review 4.  Multiplicity of hormone-secreting tumors: common themes about cause, expression, and management.

Authors:  Stephen J Marx
Journal:  J Clin Endocrinol Metab       Date:  2013-06-14       Impact factor: 5.958

5.  Characterization of β-cell plasticity mechanisms induced in mice by a transient source of exogenous insulin.

Authors:  M-C Nollevaux; J Rahier; J Marchandise; P Thurion; S Godecharles; G Van den Steen; J Jamart; C Sempoux; P Jacquemin; Y Guiot
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-02-12       Impact factor: 4.310

6.  Surgical treatment of congenital hyperinsulinism: Results from 500 pancreatectomies in neonates and children.

Authors:  N Scott Adzick; Diva D De Leon; Lisa J States; Katherine Lord; Tricia R Bhatti; Susan A Becker; Charles A Stanley
Journal:  J Pediatr Surg       Date:  2018-10-05       Impact factor: 2.545

7.  Dual origin, development, and fate of bovine pancreatic islets.

Authors:  Claudia Merkwitz; Paul Lochhead; Jan Böttger; Madlen Matz-Soja; Michiharu Sakurai; Rolf Gebhardt; Albert M Ricken
Journal:  J Anat       Date:  2012-11-21       Impact factor: 2.610

8.  Congenital hyperinsulinism caused by hexokinase I expression or glucokinase-activating mutation in a subset of β-cells.

Authors:  Jean-Claude Henquin; Christine Sempoux; Joelle Marchandise; Sebastien Godecharles; Yves Guiot; Myriam Nenquin; Jacques Rahier
Journal:  Diabetes       Date:  2012-12-28       Impact factor: 9.461

9.  Monogenic hyperinsulinemic hypoglycemia: current insights into the pathogenesis and management.

Authors:  Katherine Lord; Diva D De León
Journal:  Int J Pediatr Endocrinol       Date:  2013-02-06

Review 10.  Hyperinsulinaemic hypoglycaemia:genetic mechanisms, diagnosis and management.

Authors:  Zainaba Mohamed; Ved Bhushan Arya; Khalid Hussain
Journal:  J Clin Res Pediatr Endocrinol       Date:  2012-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.